IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
35.95
+1.61 (4.69%)
Dec 4, 2025, 4:00 PM EST - Market closed
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $3.15 billion as of December 4, 2025. Its market cap has increased by 36.88% in one year.
Market Cap
3.15B
Enterprise Value
2.05B
1-Year Change
36.88%
Ranking
Category
Stock Price
$35.95
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $3.15B, an increase of 1,362.01%. That is a compound annual growth rate of 50.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 3.01B | 35.53% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | 406.77M | 168.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |